Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,724.80
(
0.02%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
105.67
(
1.18%
)
Bitcoin
71,037.01
(
1.63%
)
News Focus
News Focus

Replies to post #150675 on Biotech Values

Replies to #150675 on Biotech Values
icon url

oc631

10/16/12 9:00 AM

#150687 RE: ThomasS #150675

ABT: having cured 52 of 53 GT1a and 24 of 24 GT1b, ABT has already addressed the lion's share of difficult to treat HCV patients.




The SVR rates were terrific and this puts pressure on GILD.